Live Breaking News & Updates on Professor Richard Hobbs

Stay updated with breaking news from Professor richard hobbs. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Asthma drug budesonide shortens recovery time in non-hospitalised patients with COVID-19

Share
Early treatment with inhaled budesonide shortens recovery time by a median of three days in patients with COVID-19 who are at higher risk of more severe illness and are treated in the community, finds Oxford University’s Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial.
PRINCIPLE is the world’s largest Phase 3 platform randomised controlled trial to find clear evidence of an effective COVID-19 treatment for use in the community that can significantly shorten recovery time. As one of the UK Government’s national priority platform trials, findings from PRINCIPLE have potential to change how COVID-19 is treated in its early stages in non-hospital, community settings in the UK and internationally. ....

United Kingdom , Fiona Watt , Richard Hobbs , Mona Bafadhel , Chris Butler , Trial Steering Committee , United Kingdom Research , University Of Oxford , Oxford University Platform Randomised Trial Of Interventions , National Institute For Health Research , Therapeutics Task , Department Of Health , Oxford University Nuffield Department Of Medicine , Research Council , Oxford University , Platform Randomised Trial , Older People , United Kingdom Government , Chief Investigator , Professor Chris Butler , South Wales , Primary Care , Nuffield Department , Primary Care Health Sciences , United Kingdom Wide , Therapeutics Taskforce ,

The FINANCIAL - Asthma Drug Shortens Recovery Time in COVID-19 Patients at Home

Share This
The FINANCIAL Early treatment with an asthma drug budesonide shortens recovery time in COVID-19 patients aged over 50 who are treated at home or in other community settings.
The Platform Randomised Trial of Interventions against COVID-19 in Older People (PRINCIPLE) trial is led by the University of Oxford. It is funded by UK Research and Innovation and the National Institute for Health Research (NIHR) through the COVID-19 Rapid Response rolling call.
It is the world’s largest Phase 3 platform randomised controlled trial to find clear evidence of an effective COVID-19 treatment for use in primary care that can significantly shorten recovery time. ....

United Kingdom , Fiona Watt , Richard Hobbs , Chris Butler , National Institute For Health Research , Therapeutics Task , United Kingdom Research , University Of Oxford , Connectivity National Core Study , Research Council , Platform Randomised Trial , Older People , National Institute , Health Research , Chief Investigator , Professor Richard Hobbs , Oxford University , Nuffield Department , Primary Care Health Sciences , Executive Chair , Medical Research Council , Professor Chris Butler , South Wales , Primary Care , United Kingdom Wide , Therapeutics Taskforce ,

The FINANCIAL - Asthma Drug Shortens Recovery Time in COVID-19 Patients at Home

The FINANCIAL - Asthma Drug Shortens Recovery Time in COVID-19 Patients at Home
finchannel.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finchannel.com Daily Mail and Mail on Sunday newspapers.

United Kingdom , Fiona Watt , Richard Hobbs , Chris Butler , National Institute For Health Research , Therapeutics Task , United Kingdom Research , University Of Oxford , Connectivity National Core Study , Research Council , Platform Randomised Trial , Older People , National Institute , Health Research , Chief Investigator , Professor Richard Hobbs , Oxford University , Nuffield Department , Primary Care Health Sciences , Executive Chair , Medical Research Council , Professor Chris Butler , South Wales , Primary Care , United Kingdom Wide , Therapeutics Task Force ,

Asthma drug 'reduces Covid-19 recovery time in those not admitted to hospital' | Burnham and Highbridge Weekly News

Budesonide is effective as a treatment at home and during the early stages of the illness, research suggests. ....

United Kingdom , Richard Hobbs , Stephen Powis , Chris Butler , Gail Hayward , University Of Oxford , Oxford University Platform Randomised Trial Of Interventions , Nuffield Department Of Primary Care Health Sciences , England National , Oxford University , Platform Randomised Trial , Older People , Professor Richard Hobbs , Nuffield Department , Primary Care Health Sciences , Professor Gail Hayward , National Medical Director , ஒன்றுபட்டது கிஂக்டம் , ரிச்சர்ட் ஹாப்ஸ் , கிறிஸ் பட்லர் , கெயில் வைக்கோல் , பல்கலைக்கழகம் ஆஃப் ஆக்ஸ்ஃபர்ட் , நுஃபையீல்ட் துறை ஆஃப் ப்ரைமரீ பராமரிப்பு ஆரோக்கியம் அறிவியல் , இங்கிலாந்து தேசிய , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , பழையது மக்கள் ,

Asthma drug 'reduces Covid-19 recovery time in those not admitted to hospital'

Budesonide is effective as a treatment at home and during the early stages of the illness, research suggests. ....

United Kingdom , Richard Hobbs , Stephen Powis , Chris Butler , Gail Hayward , Oxford University Platform Randomised Trial Of Interventions , Nuffield Department Of Primary Care Health Sciences , England National , Oxford University , Platform Randomised Trial , Older People , Professor Richard Hobbs , Nuffield Department , Primary Care Health Sciences , South Wales , Professor Gail Hayward , National Medical Director , ஒன்றுபட்டது கிஂக்டம் , ரிச்சர்ட் ஹாப்ஸ் , கிறிஸ் பட்லர் , கெயில் வைக்கோல் , நுஃபையீல்ட் துறை ஆஃப் ப்ரைமரீ பராமரிப்பு ஆரோக்கியம் அறிவியல் , இங்கிலாந்து தேசிய , ஆக்ஸ்ஃபர்ட் பல்கலைக்கழகம் , பழையது மக்கள் , ப்ரொஃபெஸர் ரிச்சர்ட் ஹாப்ஸ் ,